1. Home
  2. NBIX vs COKE Comparison

NBIX vs COKE Comparison

Compare NBIX & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Coca-Cola Consolidated Inc.

COKE

Coca-Cola Consolidated Inc.

HOLD

Current Price

$179.91

Market Cap

13.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
COKE
Founded
1992
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.4B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
NBIX
COKE
Price
$163.88
$179.91
Analyst Decision
Strong Buy
Analyst Count
22
0
Target Price
$180.91
N/A
AVG Volume (30 Days)
1.1M
649.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
0.50%
EPS Growth
41.95
156.81
EPS
1.91
1.21
Revenue
$161,626,000.00
$7,228,055,000.00
Revenue This Year
$24.73
N/A
Revenue Next Year
$13.14
N/A
P/E Ratio
$87.58
$140.41
Revenue Growth
977.51
4.76
52 Week Low
$122.14
$105.44
52 Week High
$169.57
$218.73

Technical Indicators

Market Signals
Indicator
NBIX
COKE
Relative Strength Index (RSI) 65.15 51.27
Support Level $134.92 $180.44
Resistance Level N/A $182.49
Average True Range (ATR) 4.51 6.77
MACD 0.13 1.06
Stochastic Oscillator 67.18 83.37

Price Performance

Historical Comparison
NBIX
COKE

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.

Share on Social Networks: